Primary record
2-{[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]sulfanyl}benzoic acid
- 库存
- 9,822 克
- 纯度
- 99.2 %
- CAS
- 162520-00-5
化合物标识与属性
- CAS
- 162520-00-5
- PubChem CID
- 5469318
- SMILES
- CC(=CCC/C(=C/CC/C(=C/CSC1=CC=CC=C1C(=O)O)/C)/C)C
- Canonical SMILES
- CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)O
名称与同义词
- Salirasib
- Farnesylthiosalicylic acid
- 162520-00-5
- salirasibum
- S-Farnesylthiosalicylic acid
- Salirasib [USAN]
- Salirasib?
- S-trans
- Farnesylthiosalicylate
- Salirasib; FTS
- FTS, Thyreos
- Farnesyl Thiosalicylic Acid
- farnesyl thiosalicylate
- Salirasib [USAN:INN]
- Farnesylthiosalicyclic acid
- MZH0OM550M
- SALIRASIB [INN]
- UNII-MZH0OM550M
- Ras antagonists, Thyreos
- Salirasib (INN/USAN)
- RefChem:884413
- FTS Farnesylthiosalicylate
- Lopac-F-8175
- MFCD00467723
- CHEMBL23293
- D00KTV
- D05YQY
- AC1NV5Y3
- SALIRASIB [WHO-DD]
- Lopac0_000517
- C22H30O2S
- MLS006010835
- Trans-farnesylthiosalicylicacid
- trans,trans Farnesyl Thiosalicylic Acid
- DTXSID501025654
- GTPL6281
- orb1301020
- SCHEMBL1685617
- FTS (oral, cancer), Concordia
- Salirasib, >=98% (HPLC)
- SCHEMBL29367033
- Th-101
- DTXCID70910920
- S-trans,trans-farnesylthiosalicylic acid
- CHEBI:177460
- WUILNKCFCLNXOK-CFBAGHHKSA-N
- GLXC-02963
- KD032
- AMY39921
- BCP27978
- EX-A1170
- ONO-7056
- Ras-inhibitors (cancer), Concordia
- trans,trans-Farnesylthiobenzoic acid
- ZINC1650377
- FTS (oral, cancer), Concordia/Ono
- 2030AH
- BDBM50034278
- C22-H30-O2-S
- KD-032
- NSC685986
- NSC755771
- s7684
- AKOS024458453
- CCG-204607
- CID5469318
- CS-0681
- DB12681
- FF23230
- NSC-685986
- NSC-755771
- trans,trans-Farnesyl thiosalicylic acid
- CID:5469318
- NCGC00015448-01
- NCGC00015448-02
- NCGC00015448-03
- NCGC00015448-11
- NCGC00093912-01
- NCGC00093912-02
- AC-35983
- AS-73028
- BC600693
- HY-14754
- SID:53787349
- SMR004701762
- SY115815
- FTS
- J653.317E
- LS-186975
- LS-187617
- 2-(((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)thio)benzoic acid
- 2-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]sulfanylbenzoic acid
- A3351
- A3787
- EU-0100517
- FT-0668471
- NS00068710
- J1.216.035F
- D08995
- F 8175
- W-5109
- Benzoic acid, 2-[[(2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrien-1-yl]thio]-
- A882836
- C093323
- SR-01000075885
- 2-(((2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrienyl)sulfanyl)benzoic acid
- 2-[[(2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-yl]thio]benzoic Acid
- SR-01000075885-1
- 2-((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienylthio)benzoic acid
- BRD-K98453471-001-01-7
- Farnesylthiosalicyclic acid (oral, cancer), Concordia
- Q27088685
- (E,E)-2-[(3,7,11-Trimethyl-2,6,10-dodecatrienyl)thio]benzoic Acid
- B2693-209250
- S-Farnesylthiosalicylic acid;Farnesyl Thiosalicylic Acid;FTS
- 2-[(3,7,11-Trimethyl-2,6,10-dodecatrienyl)thio]benzoic acid
- 2-[[(2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrienyl]thio]benzoic acid
- Benzoic acid, 2-(((2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrienyl)thio)-
- 2-(3,7,11-trimethyldodeca-2,6,10-trienylsulfanyl)benzoic acid
- 2-{[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]sulfanyl}benzoic acid
- 2-((2E,6E)-3,7,11-Trimethyl-dodeca-2,6,10-trienylsulfanyl)-benzoic acid
- 2-((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl)sulfanylbenzoic acid
- 2-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]sulanylbenzoic acid
- 2-[[(2E,6E)-3,7,11-Trimethyldodeca-2,6,10-trienyl]thio]benzoic acid
- 2-[[(3E,7E)-3,7,11-Trimethyl-2,6,10-dodecatrienyl]thio]benzoic acid
- 2-(((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)sulfanyl)benzoic acid
- 2-[(3,7,11-TRIMETHYLDODECA-2,6,10-TRIEN-1-YL)SULFANYL]BENZOIC ACID
- 2-[[(2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatriene-1-yl]thio]benzoic acid
- 2-[[(2E,6E)-3,7,11-Trimethyldodeca-2,6,10-trien-1-yl]thio]benzoic Acid
- 878-362-1